Total Funding
43
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 43 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
85766
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Acquired by 

Sygnature Discovery
- Marc LeBel: Co-Owner, President & Chairman
- Marc Janes: Co-Owner & Vice President of Business Development & Innovation
About the Company
NuChem Sciences is drug discovery in chemistry contract research organization (CRO) located in Montréal. It has established a diverse customer base of biotech, pharma, and academic research laboratories within North America. Its broad range of therapeutic areas including inflammation, diabetes, bone, obesity, infectious diseases, cancer, and pain.